TREM-1 amplifies inflammation and is a crucial mediator of septic shock

Nature
Axel BouchonM Colonna

Abstract

Host innate responses to bacterial infections are primarily mediated by neutrophils and monocytes/macrophages. These cells express pattern recognition receptors (PRRs) that bind conserved molecular structures shared by groups of microorganisms. Stimulation of PRR signalling pathways initiates secretion of proinflammatory mediators, which promote the elimination of infectious agents and the induction of tissue repair. Excessive inflammation owing to bacterial infections can lead to tissue damage and septic shock. Here we show that inflammatory responses to microbial products are amplified by a pathway mediated by triggering receptor expressed on myeloid cells (TREM)-1. TREM-1 is an activating receptor expressed at high levels on neutrophils and monocytes that infiltrate human tissues infected with bacteria. Furthermore, it is upregulated on peritoneal neutrophils of patients with microbial sepsis and mice with experimental lipopolysaccaride (LPS)-induced shock. Notably, blockade of TREM-1 protects mice against LPS-induced shock, as well as microbial sepsis caused by live Escherichia coli or caecal ligation and puncture. These results demonstrate a critical function of TREM-1 in acute inflammatory responses to bacteria and implic...Continue Reading

References

Oct 1, 1992·The American Journal of Surgical Pathology·F FacchettiJ J Van den Oord
Sep 21, 1991·Lancet·M P GlauserJ Cohen
Apr 1, 1991·The Journal of Experimental Medicine·H R AlexanderJ A Norton
Sep 15, 1991·Annals of Internal Medicine·R C Bone
Jan 1, 1987·Annual Review of Medicine·D C Morrison, J L Ryan
Oct 24, 1986·Science·K J TraceyJ D Albert
May 21, 1999·Science·J A HoffmannR A Ezekowitz
Jul 10, 1999·Science·H WangK J Tracey
Feb 19, 2000·Current Opinion in Microbiology·B Beutler
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A BouchonM Colonna
Aug 3, 2000·The New England Journal of Medicine·R Medzhitov, C Janeway
Aug 30, 2000·Nature·A Aderem, R J Ulevitch

❮ Previous
Next ❯

Citations

Feb 2, 2006·Intensive Care Medicine·Evangelos J Giamarellos-BourboulisCharis Roussos
Feb 2, 2006·Intensive Care Medicine·Sébastien Gibot, Frederic Massin
Mar 9, 2005·Intensive Care Medicine·Sébastien GibotBruno Lévy
Jun 21, 2006·Intensive Care Medicine·Rogier M DetermannDiederik van de Beek
Apr 9, 2008·Intensive Care Medicine·Ali A El SolhLilibeth Pineda
Aug 1, 2008·Immunogenetics·Tammy P ChengWayne M Yokoyama
Jul 5, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J BisharaY Molad
Sep 21, 2007·Current Infectious Disease Reports·François Philippart, Jean-Marc Cavaillon
Sep 21, 2007·Current Infectious Disease Reports·Willem Joost Wiersinga, Tom van der Poll
Apr 24, 2014·Indian Journal of Clinical Biochemistry : IJCB·K P MishraS B Singh
Oct 17, 2001·Developmental and Comparative Immunology·B G Magor, K E Magor
Dec 20, 2002·Nature·Jonathan Cohen
Jul 23, 2013·Nature Immunology·Nicole A de WeerdPaul J Hertzog
Dec 22, 2004·Nature Immunology·Eric Vivier, Bernard Malissen
May 17, 2005·Nature Immunology·Jessica A HamermanLewis L Lanier
Nov 18, 2006·Nature Immunology·Julia Klesney-TaitMarco Colonna
Nov 18, 2006·Nature Immunology·Philippe J Sansonetti
Jan 16, 2007·Nature Reviews. Immunology·Isaiah R Turnbull, Marco Colonna
Feb 24, 2007·Nature Reviews. Immunology·Giorgio Trinchieri, Alan Sher
Jan 19, 2013·Pediatric Research·Hector R Wong
Sep 13, 2002·Immunology and Cell Biology·Lois L Cavanagh, Ulrich H Von Andrian
Jan 30, 2004·The New England Journal of Medicine·Sébastien GibotPierre-Edouard Bollaert
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi WataraiMasaru Taniguchi
Aug 23, 2005·Medical Mycology·C M HogaboamK F Buckland
Aug 13, 2003·The Journal of Experimental Medicine·Marina CellaMarco Colonna
Nov 24, 2004·The Journal of Experimental Medicine·Sébastien GibotGilbert C Faure
Aug 3, 2005·The Journal of Experimental Medicine·Isaiah R TurnbullMarco Colonna
Oct 8, 2008·The Journal of Experimental Medicine·Karen A CavassaniSteven L Kunkel
Jun 7, 2003·The Journal of Infectious Diseases·Marco Colonna, Fabio Facchetti
Nov 17, 2007·The Journal of Infectious Diseases·W Joost WiersingaTom van der Poll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Cat-scratch disease

Cat-scratch disease, a relatively common infectious disease, is caused by Bartonella henselae and characterized by a fever and regional lymphadenitis. Here is the latest research.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.